Observational Study Relapsed or Refractory Chronic Lymphocytic Leukemia Venetoclax-based Regimens Outside Clinical Trials in Italy

NCT04282811 · clinicaltrials.gov ↗

RECRUITING

Status

321

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Relapse Leukemia
Refractory Leukemia

Interventions

DRUG: Venetoclax

Sponsor

Gruppo Italiano Malattie EMatologiche dell'Adulto